Evidence map›Paper›PMID 31794602›Full record

ArticleBlood advances2019

American Society of Hematology 2019 guidelines for management of venous thromboembolism: prevention of venous thromboembolism in surgical hospitalized patients.

David R Anderson, Gian Paolo Morgano, Carole Bennett, Francesco Dentali, Charles W Francis, David A Garcia, Susan R Kahn, Maryam Rahman, Anita Rajasekhar, Frederick B Rogers and 13 more

3 registry-linked trialsOpen access · goldAbstract readHistorical Article
In one paragraph

Article in Blood advances, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 3 registered trials, which are not on this map. Cited by 278 papers, 18 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
278citing papers in PubMed, 18 pooled it
43.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06611319 phase3recruitingnot on this mapstarted 2024, after this paper: background citation

ENhanced Recovery and ABbreviated LEngth of Anticoagulation for Thromboprophylaxis After Primary Hip Arthroplasty

TypeinterventionalSponsorProf. Stavros Konstantinides, MDRan2024 to 2027Enrolled2,932ConditionsHip Arthroplasty, Total, Prevention of Venous ThromboembolismArmsPrevention of Venous Thromboembolism, Placebo Oral Tablet
NCT07228663 phase3not yet recruitingnot on this mapstarted 2025, after this paper: background citation

Rivaroxaban Plus Acetylsalicylic Acid Versus Standard of Care for Arterial and Venous Cardiovascular Prevention After Hip Fracture Surgery in Patients With Myocardial Injury: a Pilot Randomized Trial

TypeinterventionalSponsorMcMaster UniversityRan2025 to 2027Enrolled100ConditionsHip Fracture Surgery, Cardiovascular Prevention, Venous Thromboembolism (VTE)Armsrivaroxaban and ASA, Low-molecular weight heparin, Fondaparinux, Direct Oral Anticoagulant (DOAC)
NCT07287007 narecruitingnot on this mapstarted 2025, after this paper: background citation

Evaluating the Hemodynamic Performance of the VenAir Sequential Compression System

TypeinterventionalSponsorWellell Inc. TaiwanRan2025 to 2026Enrolled105ConditionsNo Condition, Healthy Individuals, No Conditions, Aged 20-64ArmsVenAir, SCD700
3 · Its place in the literature

Who cites it

278 citing papers in PubMed, 18 syntheses or guidelines pooled it, 568 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Guideline
  6. Pooled it
  7. Pooled it
  8. Pooled it
  9. Guideline
  10. Pooled it
  11. Pooled it
  12. Pooled it
  13. Pooled it
  14. Pooled it
  15. Pooled it
  16. Pooled it
  17. Pooled it
  18. Pooled it
  19. Trial
  20. Trial

218 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors at 17 institutions in 6 countries.

David R AndersonDepartment of Medicine, Dalhousie University, Halifax, NS, Canada.
Gian Paolo MorganoDepartment of Health Research Methods, Evidence and Impact, McMaster University, Hamilton, ON, Canada.
Carole BennettShreveport, LA.
Francesco DentaliDepartment of Medicine and Surgery, Insubria University, Varese, Italy.
Charles W FrancisWilmot Cancer Center, University of Rochester Medical Center, Rochester, NY.
David A GarciaDivision of Hematology, Department of Medicine, University of Washington Medical Center, University of Washington School of Medicine, Seattle, WA.
Susan R KahnDepartment of Medicine, McGill University and Lady Davis Institute, Montreal, QC, Canada.
Maryam RahmanLillian S. Wells Department of Neurosurgery and.
Anita RajasekharDivision of Hematology and Oncology, Department of Medicine, University of Florida, Gainesville, FL.
Frederick B RogersTrauma and Acute Care Surgery, Penn Medicine Lancaster General Health, Lancaster, PA.
Maureen A SmytheDepartment of Pharmaceutical Services, Beaumont Hospital, Royal Oak, MI.
Kari A O TikkinenDepartment of Urology and.
Adolph J YatesDepartment of Orthopedic Surgery, University of Pittsburgh Medical Center, Pittsburgh, PA.
Tejan BaldehDepartment of Health Research Methods, Evidence and Impact, McMaster University, Hamilton, ON, Canada.
Sara BalduzziDepartment of Diagnostic, Clinical, and Public Health Medicine, University of Modena and Reggio Emilia, Modena, Italy.
Jan L BrożekDepartment of Health Research Methods, Evidence and Impact, McMaster University, Hamilton, ON, Canada.
Itziar Etxeandia- IkobaltzetaDepartment of Health Research Methods, Evidence and Impact, McMaster University, Hamilton, ON, Canada.
Herman JohalCenter for Evidence-Based Orthopaedics, Division of Orthopaedic Surgery, McMaster University, Hamilton, ON, Canada.
Ignacio NeumannDepartment of Internal Medicine, School of Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile.
Wojtek WierciochDepartment of Health Research Methods, Evidence and Impact, McMaster University, Hamilton, ON, Canada.
Juan José Yepes-NuñezSchool of Medicine, Universidad de los Andes, Bogotá, Colombia.
Holger J SchünemannDepartment of Health Research Methods, Evidence and Impact, McMaster University, Hamilton, ON, Canada.
Philipp DahmUrology Section, Minneapolis VA Health Care System, Minneapolis, MN; and.
Impact · CADalhousie University · CALancaster General Hospital · USLouisiana State University in Shreveport · USMcGill University · CAMcMaster University · CAPontificia Universidad Católica de Chile · CLUniversidad de Los Andes · COUniversity of Florida · USUniversity of Helsinki · FIUniversity of Insubria · ITUniversity of Minnesota · USUniversity of Modena and Reggio Emilia · ITUniversity of Pittsburgh Medical Center · USUniversity of Rochester Medical Center · USUniversity of Washington Medical Center · USWayne State University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundVenous thromboembolism (VTE) is a common source of perioperative morbidity and mortality.

objectiveThese evidence-based guidelines from the American Society of Hematology (ASH) intend to support decision making about preventing VTE in patients undergoing surgery.

methodsASH formed a multidisciplinary guideline panel balanced to minimize bias from conflicts of interest. The McMaster University GRADE Centre supported the guideline-development process, including performing systematic reviews. The Grading of Recommendations Assessment, Development and Evaluation (GRADE) approach was used to assess evidence and make recommendations, which were subject to public comment.

resultsThe panel agreed on 30 recommendations, including for major surgery in general (n = 8), orthopedic surgery (n = 7), major general surgery (n = 3), major neurosurgical procedures (n = 2), urological surgery (n = 4), cardiac surgery and major vascular surgery (n = 2), major trauma (n = 2), and major gynecological surgery (n = 2).

conclusionsFor patients undergoing major surgery in general, the panel made conditional recommendations for mechanical prophylaxis over no prophylaxis, for pneumatic compression prophylaxis over graduated compression stockings, and against inferior vena cava filters. In patients undergoing total hip or total knee arthroplasty, conditional recommendations included using either aspirin or anticoagulants, as well as for a direct oral anticoagulant over low-molecular-weight heparin (LMWH). For major general surgery, the panel suggested pharmacological prophylaxis over no prophylaxis, using LMWH or unfractionated heparin. For major neurosurgery, transurethral resection of the prostate, or radical prostatectomy, the panel suggested against pharmacological prophylaxis. For major trauma surgery or major gynecological surgery, the panel suggested pharmacological prophylaxis over no prophylaxis.

Indexed as

HematologyHistory, 21st CenturyHospitalizationHumansSurgical Procedures, OperativeUnited StatesVenous Thromboembolism

Identifiers

PMID31794602
PMCPMC6963238
OpenAlexW2991907358

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.